Drug Profile
Isopropyl pyrrolizine
Alternative Names: IPP; NSC 278214Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator State University of New York
- Developer Unimed Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Feb 1996 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 20 Feb 1995 Investigation in Cancer in USA (Unknown route)